In this study, expected known class-effect toxicities related to mTOR inhibitor therapy were observed, including anemia, hypertriglyceridemia, hyperglycemia, hypercholesterolemia, pulmonary events, and stomatitis. Here, MTOR is linked to hypertriglyceridemia.